Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | APGE Apogee Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $135.07 +0.0% | $15.37 -0.2% |
| StockIQ Score | 57C Moderate Risk: Low | 35F Weak Risk: High |
| Technical | 70B | 13F |
| Fundamental | 50C- | 35F |
| Growth | 32F | 50C- |
| Fair Value | 38F | 38F |
| News | 100A+ | 50C- |
| Quality | 55C | 50C- |
| Risk | 70B | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
APGE outperforms AAPG in most categories. Its investor score (56 vs. 38) and technical score (65 vs. 19) are significantly higher, showing stronger market sentiment and technical strength. However, AAPG has a slightly better growth score (50 vs. 32), indicating faster potential expansion. Both share the same valuation score of 38.